Stanley H. Appel Department of Neurology

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Amyotrophic Lateral Sclerosis 96%
3. Restless Legs Syndrome 62%
4. Brain 62%
5. Spinocerebellar Ataxia 10 49%
6. Myotonic Dystrophy 47%
7. Motor Neurons 45%
8. Stroke 45%
9. Alzheimer Disease 41%
10. Essential Tremor 37%
11. Tremor 36%
12. Positron-Emission Tomography 34%
13. Headache 31%
14. Spinocerebellar Ataxias 30%
15. Vascular Dementia 30%
16. Therapeutics 29%
17. Neuroimaging 28%
18. Dementia 27%
19. (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine 27%
20. Single-Photon Emission-Computed Tomography 26%
21. Cognitive Dysfunction 26%
22. Deep Brain Stimulation 26%
23. Placebos 25%
24. Genes 24%
25. Mutation 23%
26. Ataxia 23%
27. Cholinergic Receptors 21%
28. Huntington Disease 21%
29. Neurology 21%
30. Migraine Disorders 21%
31. Spinal Cord 20%
32. Pallidotomy 20%
33. Seizures 19%
34. Muscles 18%
35. Disease Progression 18%
36. Levodopa 18%
37. Magnetic Resonance Imaging 17%
38. Parkinsonian Disorders 17%
39. Proteins 17%
40. Age of Onset 17%
41. Microglia 16%
42. Alleles 16%
43. Phenotype 16%
44. Neurodegenerative Diseases 16%
45. White Matter 15%
46. Myasthenia Gravis 15%
47. Gait 15%
48. Skeletal Muscle 14%
49. Safety 14%
50. Friedreich Ataxia 14%
51. Muscular Dystrophies 14%
52. Cognition 14%
53. Movement Disorders 14%
54. Dystonia 14%
55. Rolipram 14%
56. Amyotrophic lateral sclerosis 1 13%
57. Membranes 13%
58. Blood Vessels 13%
59. Antibodies 13%
60. Clinical Trials 13%
61. Tropical Spastic Paraparesis 13%
62. Machado-Joseph Disease 13%
63. Neurologists 12%
64. Population 12%
65. Nervous System Diseases 12%
66. Cerebellar Ataxia 12%
67. In Vitro Techniques 12%
68. Mental Status and Dementia Tests 12%
69. Immunoglobulin G 12%
70. Wounds and Injuries 12%
71. Injections 12%
72. Dopamine Plasma Membrane Transport Proteins 12%
73. Stuttering 12%
74. Neurons 12%
75. Dyskinesias 11%
76. Dopamine 11%
77. Nervous System 11%
78. GABA-A Receptors 11%
79. Biomarkers 11%
80. Calcium 11%
81. Ligands 11%
82. Epilepsy 11%
83. Dopamine Agonists 11%
84. Cholinergic Agents 11%
85. Fluorodeoxyglucose F18 11%
86. Pathology 10%
87. Finches 10%
88. Amyloid 10%
89. Animal Models 10%
90. Multiple Sclerosis 10%
91. Immunoglobulins 10%
92. Type 4 Cyclic Nucleotide Phosphodiesterase 10%
93. Microsatellite Repeats 10%
94. Tomography 10%
95. Brain Diseases 9%
96. Depression 9%
97. Sleep 9%
98. Corpus Striatum 9%
99. Tetrabenazine 9%
100. Trinucleotide Repeats 9%